AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol
Lipolytic hGH fragment (AOD-9604) + GHRH analog (CJC-1295) + GH secretagogue (Ipamorelin) in one 12 mg blend — research-only, not FDA-approved.
Mixing two peptides? First read: Can I combine peptides in the same syringe?
Mix & measure AOD-9604 + CJC-1295 + Ipamorelin · 12 mg
Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.
Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →
Dosing & Reconstitution Guide
One combined 12 mg vial — educational guide for reconstitution and once-daily total-blend dosing
All doses below are stated as total blend (combined AOD-9604 6 mg + CJC-1295 3 mg + Ipamorelin 3 mg). Because all three peptides share one vial, you cannot draw a single component separately. Run once daily with gradual titration across the cycle.
Standard / Gradual Approach (3 mL = 4 mg/mL)
Reconstitute: Add 3.0 mL bacteriostatic water to the 12 mg combined vial → 4 mg/mL (4,000 mcg/mL).
Typical daily range: 400 mcg (0.4 mg) → 1,200 mcg (1.2 mg) total blend once daily, raised gradually across the cycle.
Easy measuring: At 4,000 mcg/mL, 1 unit = 40 mcg on a U-100 syringe (units = mcg ÷ 40).
Weeks 1–4
400 mcg (0.4 mg) (1× daily)
10 units (0.10 mL)
Weeks 5–8
800 mcg (0.8 mg) (1× daily)
20 units (0.20 mL)
Weeks 9–12
1,200 mcg (1.2 mg) (1× daily)
30 units (0.30 mL)
Why AOD-9604 + CJC-1295 + Ipamorelin draws research interest
These are the directions researchers and the peptide community most often explore AOD-9604 + CJC-1295 + Ipamorelin for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.
Fat metabolism & lipolysis
AOD-9604, an hGH fragment (176–191), is investigated in preclinical and early human research for stimulating lipolysis; not FDA-approved.
GH & IGF-1 support
CJC-1295 (a GHRH analog) and Ipamorelin (a GH secretagogue) are studied for stimulating the body's own growth-hormone pulses; investigational only.
Body composition
Explored in research on lean mass and fat reduction as a combined GH-axis blend; animal and investigational data only, no approved indication.
Recovery & sleep
GH secretagogues like Ipamorelin are researched for effects on slow-wave sleep and post-exercise recovery; preclinical, not approved.
Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.
Frequency: one subcutaneous injection each day at a consistent time, titrating up as tolerated over a 12-week cycle. Measure accurately with a 100-unit insulin syringe; if a calculated dose falls below 10 units, consider a smaller-capacity syringe for improved accuracy. These figures come from common supplier reference protocols, not from approved human dosing.
Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.
Reconstitution Steps
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Release it slowly down the vial’s inner wall to limit foaming.